News

Sufferers of a rare blood cell cancer will get cheap access to a new drug after an unprecedented move by the Australian government.

Despite the rarity of each of the so far 198 types of rare cancers, they account for approximately 22% of all cancer cases diagnosed in EU each year. This estimate is higher than any single common cancer and represents a significant public health issue.

Differences between breast cancer in men and women are seen in their epidemiological risk factors, molecular profiles and response to systemic therapy.

Neutrophils loaded with the chemotherapy drug paclitaxel traverse the blood-brain barrier and kill residual cancer cells after tumor-resection surgery.

DNA sequences from 100-year-old tumour samples could bolster childhood cancer research

A new treatment combining shock waves with nanoparticles can successfully treat tumours that are difficult to target using conventional chemotherapy.

These updated ESMO Clinical Practice Guidelines cover the diagnosis and pathology/molecular biology, staging and risk assessment and response evaluation of multiple myeloma.

The European Union is currently supporting an official EU call to organise a European network to pool knowledge and expertise

Knowledge of this disease is limited and mainly derives from small single-institution retrospective studies with contradictory results.

Joining up of EU's best expertise on this scale should benefit every year thousands of patients

Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma